Search

Home > GRACEcast Lung Cancer Video > ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (video)
Podcast: GRACEcast Lung Cancer Video
Episode:

ASCO Lung Cancer Highlights, Part 3: Immunotherapy for Stage III NSCLC (video)
Category: Science & Medicine
Duration: 00:08:40
Publish Date: 2013-08-13 01:44:24
Description:

Dr. David Gerber, University of Texas-Southwestern, reviews results of the START trial of tecemotide immunotherapy for stage III unresectable NSCLC.
Total Play: 0